Lilly vs Novo | Trump Talks War | China Bottleneck

The tone flipped before the open settled in. Overnight gains gave way as oil surged hard.

Futures dropped and carried that weight into the open. Early buyers stepped back as energy took control.

The prior session leaned on easing war expectations. That support faded once the timeline stretched again. Yields didn’t offer relief this time. They stayed steady while pressure built elsewhere.

By the open, positioning had already adjusted. Risk exposure was cut before the session found footing.

Oil Takes the Wheel Again

Oil is forcing faster reactions than headlines can support. That pulls buyers out before moves can build. The tape stays sensitive to anything that shifts energy again.

Not every great buy-and-hold stock is a household name. Our 7 Stocks to Buy and Hold Forever report includes under-the-radar leaders quietly dominating their niches - alongside global brands with unmatched staying power. 

Together, they form a portfolio core that can produce rising income and steady growth year after year. 

You can get the entire list free today… but only if you act before it moves behind the paywall.

Trump addressed the nation Wednesday night about the Iran war. The speech ran about 20 minutes. 

He said military operations are nearing completion and promised more strikes over the next two to three weeks. He said gas prices are temporary. He said the Strait of Hormuz will open naturally after the war ends. He did not say when.

Oil rose the moment he finished. Brent hit $106. WTI crossed $104. Stock futures dropped sharply after the close, erasing two days of gains.

Here's why the market reacted that way:

The market wasn't looking for a pep talk. It was looking for a date. It didn't get one.

The Signal 

Five weeks into this war, oil is still the only honest scoreboard. When a presidential speech sends it higher, the speech didn't answer the question that matters.

When SpaceX joins the Nasdaq-100 after 15 days, roughly $500 billion in passive funds must buy the stock. No choice involved. Twenty-one banks are now coordinating the event that makes that happen. Morgan Stanley, Goldman, JPMorgan, and more are all lined up. This isn't a normal stock listing. It's a coordinated financial event.

SpaceX wants to raise $75 billion at a $1.75 trillion valuation. For comparison, Saudi Aramco's IPO in 2019 raised $29.4 billion and was considered the largest ever. This would more than double that.

The Mechanism 

The rules were changed to attract this one listing. Passive investors absorb whatever price results. That's the part of this story that doesn't get enough attention.

President Trump just signed a new law…

That could unlock $21 trillion for everyday folks like you…

And potentially impact every checking and savings account in America.

Click here now because Chase, Bank of America, Citigroup, Wells Fargo, and U.S. Bancorp…

Are already preparing for what could be the biggest change to our financial system in 54 years.

For the past two years, GLP-1 weight loss drugs like Ozempic and Wegovy have been injections. Weekly shots. That kept millions of needle averse consumers on the sidelines. That market just opened up.

Eli Lilly received FDA approval Wednesday for Foundayo, a once-daily weight loss pill. Novo Nordisk already sells a Wegovy pill approved in January. Both are priced at $149 a month for people paying out of pocket. With insurance, the cost can drop to $25 a month.

Here's the catch. Novo's pill produces 16.6% average body weight loss in trials. Lilly's produces 12.4%. Novo's pill also has heart health approval, meaning doctors can prescribe it to reduce heart attack risk. Lilly's doesn't have that yet. Lilly's counter is simplicity. Novo's pill requires an empty stomach and a 30-minute wait before eating. Lilly's has no such rules.

The Race 

Novo has the stronger clinical results. Lilly has the easier pill to take. Millions of new patients are about to choose between them. That market share battle starts today.

This sounds embarrassing. It's actually a confidence signal, just an expensive one.

About 18 months ago, Intel was in serious trouble. So it sold a 49% stake in its Irish chip factory, to investment firm Apollo for $11.2 billion. It was a forced move to stay afloat.

This week Intel bought that stake back. The price was $14.2 billion. That's $3 billion more than Apollo paid. Intel used cash on hand and took on $6.5 billion in new debt to make it happen.

Here's what that tells you:

The company that looked fragile in 2024 is now spending aggressively to reclaim what it lost.

The Comeback 

Buying back your own factory at a premium isn't ideal. But the balance sheet that forced a fire sale is now absorbing $6.5 billion in new debt voluntarily. That's a different company than the one that needed Apollo's check in 2024.

We just found what we believe is the #1 memecoin opportunity in the market.

It’s not Dogecoin. Not Shiba Inu.
And it’s still flying under the radar.

Strong community momentum. Rare institutional interest. Real utility. Early entry — before the crowd.

The best memecoin gains go to those who move before the breakout.

See the #1 memecoin to own right now (time-sensitive).

© 2025 Boardwalk Flock LLC. All Rights Reserved. 2382 Camino Vida Roble, Suite I Carlsbad, CA 92011, United States. The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate. Readers acknowledge that the authors are not engaging in the rendering of legal, financial, medical, or professional advice. The reader agrees that under no circumstances Boardwalk Flock, LLC is responsible for any losses, direct or indirect, which are incurred as a result of the use of the information contained within this, including, but not limited to, errors, omissions, or inaccuracies. Results may not be typical and may vary from person to person. Making money trading digital currencies takes time and hard work. There are inherent risks involved with investing, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk.

There’s a contradiction at the center of U.S. AI policy.

The government wants to lead in AI, but the infrastructure depends on imports. Data centers need transformers, switchgear, and batteries. The U.S. doesn’t produce enough, so it relies on China.

In 2025, utilities imported over 8,000 large transformers from China, up from fewer than 1,500 in 2022. China also supplies over 40% of battery imports.

Lead times stretched from two years to as long as five. That delay is now the constraint. Nearly half of planned data centers this year face delays or cancellation.

Domestic manufacturers can't keep up with demand, and tariffs on imported transformers raise costs without producing a single additional domestic transformer.

The Contradiction 

America is trying to beat China in AI while building its AI infrastructure with Chinese parts. Tariffs make those parts more expensive. They don't make them appear faster.

One year ago today, Trump announced his Liberation Day tariffs. The promise was straightforward. Jobs would come back. Factories would return. The trade deficit would shrink. The national debt would fall.

Here's where things actually stand. Manufacturers have cut roughly 100,000 jobs since Trump took office. The rest of the economy added 300,000. An Ohio guitar-pedal maker spent 400 hours on tariff compliance last year and won't see a refund from the Supreme Court ruling because the money goes to her wholesaler, not her.

GM absorbed $3.1 billion in tariff costs last year and expects another $3 to $4 billion this year. Ford absorbed $2 billion and expects the same again. The average new car now costs $49,353, the biggest jump since the inflation spike years of 2021 to 2023. The national debt crossed $39 trillion in March.

Here's the real irony:

The Scorecard 

The sectors tariffs were meant to rescue are still waiting. The sectors that grew are the ones that avoided tariffs entirely. That's not the plan that was sold a year ago.

Every commitment made this morning is being scored against what it actually produced.

Trump promised the strait opens naturally after the war. Oil rose the moment he finished speaking. Lilly got FDA approval with weaker clinical results and is betting convenience beats efficacy. Intel bought back its own factory for $3 billion more than it sold it for. The AI buildout that's supposed to beat China runs on Chinese parts with five-year lead times. And Liberation Day turned one year old with automakers billions poorer, an Ohio guitar-pedal maker out of pocket on compliance costs she'll never recover, and the sectors tariffs were meant to rescue still waiting.

The gap between the promise and the delivery isn't closing. The market is settling into that reality one position at a time.